Inclusion of cycle threshold (CT) values when reporting SARS-CoV-2 RT-PCR results improves clinical Interpretation in suspected and confirmed COVID-19
Peter V. Coyle; Naema Hassan Al Molawi; Mohamed Ali Ben Hadj Kacem; Reham Awni El Kahlout; Einas Al Kuwari; Abdullatif Al Khal; Imtiaz Gilliani; Andrew Jeremijenko; Hatoun Saeb; Sheikh Mohammad Al Thani; Roberto Bertollini; Hanan F. Abdul Rahim; Hiam Chemaitelly; Patrick Tang; Ali Nizar Latif; Saad Al Kaabi; Muna A. Rahman S. AlMaslamani; Brendan David Morris; Nasser Al-Ansari; Anvar Hassan Kaleeckal; Laith J. Abu Raddad
Show abstract
Introduction: The Cycle Threshold (CT) value in Real-time Polymerase Chain Reaction (RT-PCR) is where a target specific amplification signal becomes detectable and can infer viral load, risk of transmission and recovery in SARS-CoV-2 infections. Adoption into routine practice is however uncommon. Gap Statement: The lack of inclusion of CT values when reporting SARS-CoV-2 RT-PCR results in routine practice. Aim: To use CT values when reporting SARS-CoV-2 RT-PCR results in Qatar to aid clinical interpretation and patient management. Methodology: Routine CT values across 3 different RT-PCR platforms were reviewed for concordance at presentation and clearance in patients with COVID-19. An Indicative Threshold of CT 30 based on viral clearance kinetics categorized low and high CT values. Results: There was very high Correlation and Kappa Score agreement between the different gene targets in each platform (p<0.001). Using the Indicative Threshold it was possible to autoverify and add average CT values and append Interpretive Comments to all RT-PCR reports. The new reporting algorithm impacted immediately and safely on: physician interpretation of SARS-CoV-2 results; patient management; staff surveillance protocols; length of stay in quarantine; a redefinition of patient recovery. Conclusion: Incorporation of CT values into routine practice is possible across different RT-PCR platforms and adds useful information for patient management. The use of an Indicative Threshold and interpretive comments improves clinical interpretation of the result and could be a model for reporting other respiratory infections. The current accepted practice of withholding CT values should be reviewed by the profession, accreditation bodies and regulators.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Laboratory and field evaluation of the STANDARD Q and Panbio™ SARS-CoV-2 antigen rapid test in Namibia using nasopharyngeal samples 97%
- Evaluating diagnostic accuracies of Panbio ™ COVID-19 rapid antigen test and RT-PCR for the detection of SARS-CoV-2 in Addis Ababa, Ethiopia using Bayesian Latent-Class Models (BLCM) 96%
- An international, interlaboratory ring trial confirms the feasibility of an open-source, extraction-less “direct” RT-qPCR method for reliable detection of SARS-CoV-2 RNA in clinical samples 96%
Similar papers in this journal
Similar papers in this journal
- Test Agreement Between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges 96%
- Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution 95%
- Validation and multi-site deployment of a lyophilized qRT-PCR reagent for the molecular diagnosis of avian influenza and rabies in Sub-Saharan African regions 95%
Similar papers in this journal
- Evaluation of seven different rapid methods for nucleic acid detection of SARS-COV-2 virus 96%
- Real-life performance of a novel antigen detection test on nasopharyngeal specimens for SARS-CoV-2 infection diagnosis: a prospective study 96%
- Validation and Performance Comparison of Three SARS-CoV-2 Antibody Assays 96%
Similar papers in this journal
- The Value of Rapid Antigen Tests to Identify Carriers of Viable SARS-CoV-2 97%
- High throughput Next-Generation Sequencing Respiratory Viral Panel: A Diagnostic and Epidemiologic Tool for SARS-CoV-2 and Other Viruses. 96%
- Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID 19) Virus-Neutralizing Antibodies in Human Clinical Samples 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.